Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could Novo Nordisk Stock Help You Become a Millionaire?


Novo Nordisk (NYSE: NVO), the company behind the popular weight-loss treatment Wegovy and diabetes medication Ozempic (also used by many for weight loss), has been a buy in recent years. Currently, it's trading at a 52-week high, and sales have been soaring. With a bright future ahead, does the stock have what it takes to be a millionaire-making investment?

Sales have taken off for Novo Nordisk, largely due to the strength of its obesity care treatments, which doubled in revenue last year. For five years, the company's sales have been rising sharply:

NVO Revenue (TTM) Chart

Continue reading


Source Fool.com

Like: 0
NVO
Share

Comments